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Abstract
Much effort has been spent recently in identifying host factors required for HIV-1 to effectively
replicate in cultured human cells. However, much less is known about the genetic factors in vivo that
impact viral replication in lymphatic tissue, the primary anatomical site of virus-host interactions
where the bulk of viral replication and pathogenesis occur. In order to identify genetic determinants
in lymphatic tissue that critically affect HIV-1 replication, we used microarrays to transcriptionally
profile and identify host genes expressed in inguinal lymph nodes that were associated determinants
of viral load. Strikingly, ~95% of the transcripts (558) in this data set (592 transcripts total) were
negatively associated with HIV-1 replication. Genes in this subset (1) inhibit cellular activation/
proliferation (ex.: TCFL5, SOCS5 and SCOS7, KLF10), (2) promote heterochromatin formation
(ex.: HIC2, CREBZF, ZNF148/ZBP-89), (3) increase collagen synthesis (ex.: PLOD2, POSTN,
CRTAP), and (4) reduce cellular transcription and translation. Potential anti-HIV-1 restriction factors
were also identified (ex.: NR3C1, HNRNPU, PACT). Only ~5% of the transcripts (34) were
positively associated with HIV-1 replication. Paradoxically, nearly all these genes function in innate
and adaptive immunity, particularly highlighting a heightened interferon system. We conclude that
this conventional host response cannot contain HIV-1 replication and, in fact, could well contribute
to increased replication through immune activation. More importantly, genes that have a negative
association with virus replication point to target cell availability and potentially new viral restriction
factors as principal determinants of viral load.
Introduction
Over the last decade, systems biology has taken on an increasingly important role in
investigating microbial diseases, delineating salient features of the host-pathogen relationship,
and identifying potential host genes that are critical determinants of microbial replication and
pathogenesis. In the case of HIV-1, which like any obligate intracellular pathogen relies on the
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transcriptional and translational machinery of the host cell to complete its life cycle (1–3), these
studies have revealed components of host gene expression that establish a favorable
intracellular environment for efficient virus replication. For example, genomics-based
approaches have thus far documented changes in gene expression in cultured cells during
HIV-1 infection (4), and more recently, siRNA technology has identified hundreds of host
genes seemingly indispensable for HIV-1 replication in vitro (5–8).
In contrast, much less is known about host genes that play important roles in viral replication
in vivo where HIV-1 replicates in the complex environment of lymphatic tissue (LT)3 in the
context of a host responding to infection. In previous microarray studies of HIV-1 infection in
LT, we have shown that infection massively perturbs host gene expression and that this
transcriptional profile is highly dependent on stage of disease (9). Here we report studies that
go beyond this initial identification of stage-specific features of the host response in LT to now
identify genes that play important roles in viral replication in vivo. We now show that: (1) there
is little overlap between genes in vivo compared to genes in vitro that correlate with viral
replication; (2) paradoxically, host immune responses correlate with high viral loads; and (3)
~95% of the correlations are inverse correlations that point to the importance of target cell
availability, cellular activation, transcriptional factors, and new inhibitors as determinants of
viral load in vivo.
Materials & Methods
Ethics statement
This study was conducted according to the principles expressed in the Declaration of Helsinki.
The study was approved by the Institutional Review Board of the University of Minnesota. All
patients provided written informed consent for the collection of samples and subsequent
analysis.
Lymph node biopsy specimens
Inguinal lymph node biopsies from 22 untreated HIV-1-infected individuals at different clinical
stages were obtained for this University of Minnesota Institutional Review Board-approved
microarray study. Viral load measurements were obtained the same day as biopsies. Each
lymph node biopsy was placed into a Falcon tube and snap frozen by dropping it into liquid
nitrogen.
RNA extraction, synthesis of biotin-labeled cRNA probes, and microarray hybridization
Frozen lymph nodes were homogenized with a power homogenizer (Heat Systems Ultrasonic)
in TRIzol (Invitrogen) without thawing. Total RNA was isolated according to the
manufacturer’s protocol and further purified with an RNeasy Mini Kit (Qiagen). Double
stranded cDNA and biotin-labeled cRNA probes were synthesized from 5 µg of total RNA
with a MessageAmp II aRNA kit (Ambion). The cRNA probes were column purified and
fragmented with a Fragmentation kit (Ambion).
Fifteen micrograms of fragmented cRNA was hybridized to an Affymetrix Human Genome
U133 Plus 2.0 array. After hybridization, chips were washed, stained with streptavidin-PE, and
scanned with GeneChip Operating Software at the Biomedical Genomics Center at the
University of Minnesota. The experiments from each RNA sample were duplicated in the
preparation of each cRNA probe and microarray hybridization.
3Abbreviations used in this paper: LT, lymphatic tissue; CIA, chronic immune activation; PKR, dsRNA-dependent protein kinase.
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Microarray data analysis
The .cel files produced by the Affymetrix data analysis platform were uploaded into the
Expressionist program (Genedata, Pro version 4.5) and the expression level for each of the
~56,000 probe sets on the arrays was quantified using the RMA algorithm. The mean
expression level from duplicate chips from the same individual’s RNA was computed and used
in the subsequent analysis. The RMA algorithm produces a summary of gene expression that
is of log scale; we utilized this log scale for all analyses.
To examine the relationship between gene expression and viral load, a linear regression model
was fit with gene expression as the response variable and disease stage and the log of viral load
as predictor variables. We controlled for disease stage when examining the relationship
between viral load and gene expression because we previously found an association between
gene expression and disease stage for HIV-1 infection (9) (additionally, there is an association
between disease stage and viral load for HIV-1-infected subjects naïve to HAART). The p-
values for the null hypothesis (testing no association between viral load and gene expression)
were then transformed to q-values using the q-value package in the statistical software program
R. By varying the threshold for the q-values, one can obtain a set of genes that are found to be
associated with viral load at a given false discovery rate. As the number of genes found to be
associated with viral load increases dramatically as this threshold rises above ~7%, we used
the conservative cut-off value of 7% for the false discovery rate. To summarize the association
between log of viral load and gene expression, we computed the partial correlation between
these two quantities for all genes while controlling for the effect of disease stage.
Immunofluorescence
Immunofluorescence was performed using a biotin-free detection system on 5-µm tissue
sections mounted on glass slides. Tissues were deparaffinized and rehydrated in deionized
water. Heat-induced epitope retrieval was performed using a water-bath (95–98°C for 10–20
min) in DiVA Decloaker (Biocare Medical) retrieval buffer, followed by cooling to room
temperature. Tissues sections were then treated with Proteinase K (4 µg/ml) for 20 min at 37°
C followed by blocking with SNIPER Blocking Reagent (Biocare Medical) for 15 min at room
temperature. A primary antibody specific for collagen type 1 (Sigma, clone Col-1, catalog #
C2456) was diluted 1/100 in TNB (0.1M Tris-HCl, pH 7.5; 0.15M NaCl; 0.05% Tween 20
with Dupont blocking buffer) and incubated overnight at 4°C. After the primary antibody
incubation, sections were washed with PBS and then incubated with fluorophore-cojugated
secondary antibodies (Alexa Fluor dyes, Invitrogen) in 5% non-fat milk for 2 hr at room
temperature. These sections were washed and mounted using Aqua Poly/Mount (Polysciences
Inc.). Immunofluorescent micrographs were taken using an Olympus BX61 Fluoview confocal
microscope with the following objectives: x20 (0.75 NA), x40 (0.75 NA), and x60 (1.42 NA);
images were acquired using Olympus Fluoview software (version 1.7a). Isotype-matched IgG
or IgM negative control antibodies in all instances yielded negative staining results.
Microarray data accession number
All microarray results have been deposited in the Gene Expression Omnibus database:
http://www.ncbi.nlm.nih.gov/geo/ (accession number: GSE21589).
Results
Predominance of negative correlations with viral replication
To identify genes within LT related to viral replication, we examined host gene expression and
its association with viral load in inguinal lymph nodes from 22 HIV-1-infected individuals
(Table 1). We identified 592 transcripts significantly associated with viral load (–0.6 > partial
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correlation coefficient > 0.6; 7% false discovery rate) (Figure 1A). Strikingly, ~95% of the
transcripts (558) in this data set are negatively associated with HIV-1 replication while only
~5% (34 transcripts) have a positive association (Figure 1B). Based on gene ontology/
annotations from the NetAffx Analysis Center, Ingenuity Pathways Analysis, and extensive
examination of published literature, we classified ~60% of all altered transcripts into functional
categories, resulting in a list of 345 genes (the remaining transcripts have as of yet no
identification or functional information available) (Figures 2, 4, & Supplementary Table 1).
Antiviral host response positively correlates with virus replication
Surprisingly, only a small subset of genes was positively associated with viral replication (32
genes + 2 transcripts of unknown function), with most of these genes (~70%) paradoxically
coding for proteins involved in innate and adaptive defenses, which might have been expected
to decrease viral load (Figure 2). Interferon-stimulated genes were a prominent component of
this response (16 of the 22 genes ascribed to immune defenses), but there were also genes
encoding proteins involved in cell-mediated cytotoxicity, (granzyme H, perforin, CD8, and
NKG7), antiviral chemokines (RANTES and MIP-1β), and ligands for the chemokine receptor
CXCR3 (CXCL9, CXCL10, and CXCL11). Finally, STAT1, a master regulator of transcription
of numerous immune defense genes, was also positively associated with HIV-1 replication. In
sum, this analysis reflects a robust antiviral host response that parallels virus replication but is
apparently associated with higher viral loads rather than containment of HIV-1 replication.
In a previous analysis of LT comparing uninfected to HIV-1-infected individuals (9), we found
signatures of gene expression dependent on stage of disease, with the most striking signature
in early infection where expression of genes that control immune activation and innate and
adaptive immune defenses was highly upregulated. Since immune activation is now widely
believed to be a factor in overall immune dysfunction and negative prognosticator of disease
progression (10,11), we used a chronic immune activation (CIA) index based on gene
expression, developed by Rempel et al. (12), to characterize cellular immune dysfunction
during HIV-1 infection. This index is comprised of genes related to immune activation that are
elevated during infection and can be computed for each infected individual by taking the mean
fluorescence intensity of specified genes for each sample and calculated as follows:
where n equals the number of selected genes. Here, we explored the relationship between CIA
and viral replication in our study cohort. We used 18 genes for the CIA index, genes which
had the highest increase in expression in LT during HIV-1 infection (9) (Figure 3A). The CIA
values and viral load measurements were plotted for each individual, revealing a significant
association between CIA and viral load (r = 0.6288, p < 0.0001) (Figure 3B). Additionally,
these LT genes with the highest upregulation upon infection also have the strongest positive
correlation to viral load (Figure 3A). Overall, this analysis provides a glimpse into the intricate
relationship between immune defenses, immune activation, and viral replication, whereby
individuals with a higher CIA index are more likely to have higher viral loads.
Negative correlations: immune activation and transcriptional accessibility important for
HIV-1 replication
Strikingly, the vast majority of host genes expressed in LT during HIV-1 infection were
negatively associated with virus replication (313 genes + 245 transcripts of unknown function).
A large proportion of genes in this data set encode for proteins involved in immune activation,
target cell availability, and transcriptional/translational metabolism (Figure 4), highlighting
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the importance of activation status and cellular transcriptional/translational machinery in virus
replication. In this list of genes negatively correlated with viral load (Supplementary Table 2),
there are genes involved in inhibiting cellular activation and proliferation, such as the
suppressors of cytokine signaling, SOCS5 and SCOS7; TCFL5/Cha, a transcription factor
implicated in the maintenance of a resting state in T cells; CCNG2, an unconventional cyclin
which blocks cell cycle entry; KLF10, a transcription factor involved in inhibiting cellular
proliferation through the TGF-β signaling pathway; and GPR83, a G protein-coupled receptor
involved in the generation of Foxp3+ TReg cells.
We also identified genes that regulate the intracellular environment for virus replication, such
as genes involved in suppressing cellular transcription, particularly through the modification
of DNA histones (Supplementary Table 3). Examples include genes whose products recruit
histone deacetylases, such as CREBZF and ZNF148/ZBP-89; genes whose products interact/
recruit histone methyltransferases, such as HP1BP3, HIC2, and DPF3. This analysis suggests
that these gene products adversely affect virus replication by modifying DNA histones,
promoting heterochromatin formation, and suppressing cellular and viral transcription.
Negative correlations: collagen deposition and virus replication
One pathological hallmark of HIV-1 infection is the aberrant deposition of collagen and
consequent fibrotic damage in both gut and LT (13), a process which may have adverse
consequences for the maintenance and preservation of CD4+ T cells and overall immune
function in these anatomical niches. Here we show that genes related to collagen synthesis/
deposition are negatively associated with virus replication (Supplementary Table 4). Examples
include PLOD2, an enzyme responsible for the irreversible cross-linking of collagen fibers;
POSTN, a regulator of collagen fibrillogenesis; CRTAP, a scaffolding protein linking collagen-
synthesizing enzymes to their precursor substrates; CTHRC1, a regulator of TGF-β
responsiveness and their target genes such as collagens; COL4 and COL13, collagen members
important for the structure of the basement membrane. The products of these genes likely
increase overall collagen deposition and fibrosis in LT and negatively affect virus replication
by potentially decreasing the viability/availability of target immune cells for HIV-1.
To examine this in more detail, we explored the relationship between mRNA expression of a
collagen-synthesizing gene and the resulting end product of this process, protein levels of
collagen deposited in LT. One gene we looked at was PLOD2, a telopeptide lysyl hydroxylase
primarily responsible for increasing pyridinoline cross-links within collagen molecules during
fibrillogenesis, a process which leads to the irreversible accumulation of collagen in fibrotic
tissues (14). We used immunofluorescence to visualize collagen type I deposition in inguinal
lymph nodes from HIV-1-infected individuals in our study cohort. We initially compared
subject WU59 with GL38 because of their divergent PLOD2 mRNA expression (Figure 5A)
and found a relationship between PLOD2 mRNA expression and collagen type I deposition,
whereby greater levels of fibrosis were detected in the lymph node of subject GL38 coincident
with higher levels of PLOD2 mRNA (compare Figures 5B & 5C). Previously reported to be
increased during HIV-1 infection (15), much less collagen deposition was seen in the lymph
node of an uninfected individual (Figure 5D). There was also a negative correlation between
collagen deposition in LT and numbers of peripheral blood CD4+ T cells in a group of our
study subjects (Figure 5E), in agreement with previous reports (15,16), suggesting that
increased fibrosis during HIV-1 infection may negatively impact viral replication by adversely
affecting CD4+ T cell viability and reducing access to and availability of target cells for viral
replication.
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Candidates for new host restriction factors
In our list of genes negatively associated with viral load, we identified genes potentially
encoding anti-HIV-1 restriction factors (Supplementary Table 5). One such gene is an
intracellular glucocorticoid receptor known as nuclear receptor subfamily 3, group C, member
1 (NR3C1). This receptor has been shown to impede proviral integration in peripheral blood
mononuclear cells in the absence of steroidal ligands (17); this block is alleviated in the
presence of NR3C1’s ligand and requires the HIV-1 protein, Vpr. Another candidate restriction
factor is CUG triplet repeat, RNA binding protein 1 (CUGBP1), a previously unrecognized
downstream effector of IFN-β signaling in primary macrophages that induces a transcriptional
inhibitory protein that works to suppress HIV/SIV replication (18). Heterogeneous nuclear
ribonucleoprotein U (HNRNPU) is another candidate identified in our analysis, a
ribonucleoprotein that has been shown to specifically target the 3' long terminal repeat in the
viral mRNA and block the cytoplasmic accumulation of HIV-1 mRNAs (19).
Discussion
The major and unexpected finding of this study is the unique transcriptome profile in LT during
HIV-1 infection related to viral replication, whereby the vast majority of changes in mRNA
expression are negatively associated with HIV-1 replication while only a small subset of genes
(~5%) is positively associated with virus levels. Surprisingly, most of the genes in this small
subset mediate innate and adaptive defenses mounted by the host to contain HIV-1, a host
response that would have been expected to negatively correlate with viral load. While counter-
intuitive, this LT analysis is in agreement with a transcriptome analysis of primary, peripheral
blood CD4+ T cells from HIV-1-infected individuals (20), where expression of a large
proportion of interferon-related genes also correlated with increasing levels of virus
(Supplementary Table 6).
In addition to a heightened IFN response, key genes important for cell-mediated immunity
(e.g., perforin, granzyme H, CD8, NKG7) (Figure 2) and recruitment of immune cells to sites
of infection (e.g., CXCL9, CXCL10, CXCL11) (21) were also positively associated with
HIV-1 replication. Interestingly, granzyme H, in addition to its pro-apoptotic function as a
serine protease highly expressed in natural killer cells and closely related to granzyme B (22,
23), has recently been shown to mediate antiviral activity through direct cleavage of
intracellular viral substrates (24,25). Genes related to chemotaxis may provide some clues
regarding the surprising association between host defense genes and high viral loads—the
chemotactic response may actually be part of a double-edged sword, on the one hand, serving
to recruit HIV-1-specific cytotoxic CD8+ T cells to eliminate virus-infected cells (26) but, on
the other hand, serving to fuel the infection further by recruiting susceptible, activated CD4+
T cells to the virus, ultimately aiding in viral dissemination (27).
Surprisingly, we did not identify classical activation markers such as Ki-67, HLA-DR, CD69,
CD38 in our data set, genes predicted to be positively correlated with virus replication due, in
part, to their role in cellular activation as a means to provide the virus with additional target
cells for infection. One interpretation would be that these gene products actually represent
general activation of the immune system as a whole and are not specifically indicative of
activation in the subsets of cells that are specific targets of the virus. In other words, these
classical activation markers may not be the primary determinants of a suitable intracellular
environment for permissiveness in target cells. The genes we did detect with a positive
correlation to viral load may actually be more representative of cellular activation and
permissiveness in individual target cells. The significant association between the CIA index
and viral load suggests that this may indeed be the case (Figure 3).
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How then to explain the paradoxical, positive association between host defenses and viral load,
and even more strikingly, the negative correlations that dominate the dataset? One explanation
could be that HIV-1 itself is driving host gene expression; for example, as virus replication
increases, the host responds comparably by increasing expression of genes controlling immune
defenses. However, due to the complex relationship between immune defenses, immune
activation, and virus replication, another explanation could be a model in which the level of
viral replication is determined by a balance between both factors that provide virus access to
the largest number of susceptible host cells and increase replication and factors that decrease
target cell availability/permissiveness and inhibit viral replication (Figure 6). This schematic
is consistent with a previous model proposed from transcriptional profiling of the response to
HAART (28), aimed to explain the slow progress of HIV-1 infection. On one side of the balance
are the supportive determinants of viral replication, such as target cell availability, the
activation state of CD4+ T cells and other susceptible cells, and intrinsic intracellular factors
that support replication. On the other side of the balance are innate and adaptive defenses and
host restriction factors that suppress HIV-1 replication. In this model, host defenses likely
inhibit viral replication to some extent, yet, because they are inseparable from immune
activation, related pro-inflammatory cytokines, and recruitment of activated target cells, on
balance host defenses actually may contribute to increased viral load.
In this model, many of the negatively associated genes that dominate the data set reflect the
importance of target cell availability and the ability of host intracellular machinery to support
viral replication. Collagen deposition in this model negatively impacts viral load through
fibrotic damage of the lymph node niche and its documented effects of decreasing CD4+ T
cells (Figure 5E) (15, 16), essentially decreasing access and opportunities for virus to interact
with target cells.
There may also be a complex relationship between collagen deposition, regulatory T cells
(TReg cells), and HIV-1 replication, suggested by findings in the rhesus macaque model of SIV
infection that TGF-β1-producing TReg cells are primarily responsible for inducing collagen
synthesis/deposition in LT (29). In HIV-1 infection, TReg cells might dampen cellular
activation in bystander immune cells, a classical feature of TReg cells (30), thus decreasing
overall viral output in HIV-infected cells. This would explain why GPR83, a G protein-coupled
receptor reported to be involved in the peripheral generation of TReg cells in vivo (31,32), along
with mediators of the TGF-β signaling pathway (e.g., ITGB8, SMAD5, PEG10, GDF10,
KLF10), are all negatively associated with HIV-1 replication.
Beyond the principal hypothesis of target cell availability and permissiveness as the key
determinant of viral load, there may be new, host restriction factors that also play an important
role. By identifying genes that are both negatively associated with virus replication and code
for proteins that display antiviral properties, we found several candidate genes that fit into this
category (Supplementary Table 5). One gene in this list, PACT, warrants additional comment.
PACT encodes a protein kinase that acts upstream of the important antiviral, sentinel-like
molecule, dsRNA-dependent protein kinase (PKR) (33). PACT has been shown to serve as a
cellular activator of PKR in the absence of viral RNA (34) but has also recently been
demonstrated to possess a role in type I IFN production during viral infection, specifically
bypassing PKR activation during amplification of the IFN response (35). Thus, we have a gene
that acts upstream of the IFN-response pathway and is negatively associated with viral
replication in a data set in which all other IFN-responsive genes are positively associated with
HIV-1 replication. This may indicate that PACT is acting outside the IFN-response pathway
and adversely affecting HIV-1 replication through its other functions, such as inhibiting cellular
translation and inducing apoptosis (36) or amplifying levels of micro RNAs (37) which may
serve to inhibit HIV-1 replication (38, 39). We are currently investigating PACT and other
candidate genes for their potential role as novel anti-HIV-1 restriction factors.
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We have previously documented changes in LT gene expression during HIV-1 infection and
found that infection substantially alters the transcriptional profile compared to uninfected
individuals (9) and that these transcriptional changes are dependent on stage of disease. A
comparison between the present analysis and our previous microarray findings is challenging
because the previous study stratified changes in gene expression based on disease stage while
our current analysis stratifies gene expression based strictly on virus levels, variables which
do not share high concordance (virus levels vs. disease stage). Nevertheless, when comparing
the present analysis with our previous microarray findings, we find that the majority of genes
positively associated with virus levels are significantly upregulated early in infection (acute
stage of disease), overlapping data illustrating a shared relationship between immune defense
genes and viral levels in early disease. In contrast, most of the genes negatively associated with
virus levels do not overlap with our previous dataset, illustrating the overall discordance
between disease stage and virus levels. One would expect to observe greater concordance
between datasets if viral levels were indeed correlated with disease stage, but even in our
limited study cohort, viral levels vary appreciably across stage. Thus, this comparative analysis
highlights two sets of genes—one set of genes may be directly influencing virus replication
(current study) and another set of genes that are stage dependent and, on a global scale, may
impact virus replication through direct or indirect means (9).
In this microarray study, we utilized whole lymph nodes for processing and generation of the
template RNA for microarray chip hybridization as a means to capture the sum of all
interactions in an important microenvironment (lymph node) where the bulk of HIV-1
replication and pathogenesis occur. As such, cells were not first separated into individual
subpopulations for RNA preparation (i.e., CD4+ T cells). Thus, one complexity is that the
cellular composition within the lymph node is not defined at the outset of the experiment.
However, this type of tissue microarray study can be most advantageous in that RNA from all
the essential cell populations residing within the lymph node microenvironment are present
during chip hybridization and subsequent analysis. Genes identified in this study are a good
starting point for further investigations of their roles in HIV-1 replication and pathogenesis
using in situ technologies to identify the types of cells in which gene expression has been altered
and immunohistochemistry/immunofluorescence to identify potential changes in protein
expression. For example, we used immunofluorescence to identify the cellular expression of
SP100, an IFN-responsive gene that codes for one of the major components of a nuclear
transcriptional complex known as the Promyelocytic Leukemia Nuclear Body (40) and has
been reported to play an important role in innate antiviral defense against a number of different
DNA and RNA viruses (41,42). We found the size and number of SP100-containing nuclear
bodies increased in LT CD3+ T cells and CD163+ macrophages during HIV-1 infection
compared to uninfected individuals (Supplementary Figure 1). In sum, we believe this global,
tissue microarray methodology is an important first step in a systems-biology approach to
understand HIV-1 infection that provides a future framework for focused investigations
examining the roles of specific genes impacting HIV-1 replication and pathogenesis.
This microarray study revealed very little overlap (< 3%) with recent small-interfering RNA-
knockdown screens (5–8) designed to identify host cell factors required for productive HIV-1
infection in vitro (Supplementary Table 7). This could be due to differences between in vitro
systems using laboratory-adapted strains of HIV-1 and cell lines vs. biopsied lymph nodes
from HIV-1-infected persons.
In summary, this work yields key insights into systems biology of HIV-1 infection in LT,
generates fruitful starting points for additional investigations into candidate genes that may
play an important role in aiding or inhibiting HIV-1 infection, and may identify adjunctive
approaches to improve therapies and immune reconstitution.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. The majority of transcripts in lymphatic tissue are negatively associated with viral load
(A) Histogram of the partial correlation coefficients for each transcript in the Affymetrix
Human Genome U133 Plus 2.0 array. The partial correlation coefficient represents the strength
of association between viral load and gene expression while controlling for stage of disease.
Transcripts with an absolute value exceeding 0.6 were deemed differentially expressed while
controlling for a false discovery rate of 0.7. (B) Pie chart depicting the number of transcripts
remaining after applying the selection criteria (−0.6 > partial correlation coefficient > 0.6; 7%
false discovery rate). The green and red sectors identify transcripts with a negative and positive
association, respectively, between gene expression and viral load.
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Figure 2. Differentially-expressed genes in HIV-1-infected lymphatic tissue can be classified into
functional categories
Genes positively associated with viral load reveal a heightened IFN response. The size of each
sector in a pie diagram is proportional to the number of genes in its category (in parentheses).
All genes and their names derived from abbreviations can be found in Supplementary Table
1.
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Figure 3. Chronic Immune activation correlates with HIV-1 viral load
(A) The top 18 genes in lymphatic tissue during HIV-1 infection with the highest increase in
expression (9) and strongest correlation to viral load were chosen for the CIA index
computation. The stage of disease at which the gene’s expression is increased is also listed.
(B) The CIA index for HIV-1-infected individuals is significantly correlated with peripheral
blood viral load.
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Figure 4. Differentially-expressed genes in HIV-1-infected lymphatic tissue can be classified into
functional categories
Genes negatively associated with viral load point to immune activation, target cell availability,
and transcriptional/translational factors as important determinants for HIV-1 replication. The
size of each sector in a pie diagram is proportional to the number of genes in its category (in
parentheses). All genes and their names derived from abbreviations can be found in
Supplementary Table 1.
Smith et al. Page 15
J Immunol. Author manuscript; available in PMC 2011 November 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 5. Increases in PLOD2 mRNA levels in lymphatic tissue correspond to increased collagen
type I synthesis/deposition and decreased CD4+ T cells
(A) PLOD2 mRNA expression in inguinal lymph node is negatively associated with viral load.
Yellow, blue, and green points represent subject #’s WU59, GL38, and remaining cohort
individuals, respectively. (B, C, & D) Representative immunofluorescent micrographs reveal
collagen type I deposition (red) in the paracortical T cell zone of inguinal lymph nodes from
subject #’s WU59 (B), GL38 (C), and an uninfected individual (D). (E) Collagen type I
deposition in inguinal lymph nodes is inversely correlated with numbers of peripheral blood
CD4+ T cells (Pearson’s correlation coefficient). Original magnifications: X400; scale bars:
50 µm.
Smith et al. Page 16
J Immunol. Author manuscript; available in PMC 2011 November 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 6. HIV-1 infection in lymphatic tissue is determined by a balance of factors that increase or
decrease virus replication
In this hypothetical model, HIV-1 replication within lymphatic tissue is largely determined by
a balance of factors that support or inhibit virus replication. Supportive determinants include
target cell availability, cell activation, and intracellular intrinsic factors that promote a
favorable transcriptional/translational environment. These supportive determinants are
counterbalanced by inhibitory determinants such as innate and adaptive immune responses as
well as intracellular host restriction factors that suppress virus replication. This delicate
balance, though, is altered by inflammation, a chemotactic response that recruits susceptible
target cells to sites of infection, and chronic immune activation required to maintain immune
defenses, ultimately tipping the scale towards continued HIV-1 replication and pathology.
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